Novel photosensitizer-protein nanoparticles for Photodynamic therapy: Photophysical characterization and in vitro investigations

Journal of Photochemistry and Photobiology B: Biology

Volumn 96, Issue 1, 2009, Pages 66-74

  Chen, Kuan ^a   Preuß, Annegret ^a   Hackbarth, Steffen ^a   Wacker, Matthias ^b   Langer, Klaus ^c   Röder, Beate ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Endocytosis; EPR effect; Human serum albumin; Nanoparticles; PDT; Pheophorbide a

Indexed keywords

HUMAN SERUM ALBUMIN; HUMAN SERUM ALBUMIN 100; HUMAN SERUM ALBUMIN 40; NANOPARTICLE; PHEOPHORBIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; QUANTUM YIELD;

CASPASE 3; CELL LINE, TUMOR; CHLOROPHYLL; HUMANS; JURKAT CELLS; NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SERUM ALBUMIN; SINGLET OXYGEN; SPECTROMETRY, FLUORESCENCE; TIME FACTORS;

EID: 67349217907     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2009.04.006     Document Type: Article

References (31)

1. Röder B. Photodynamic therapy. In: Meyers R.A. (Ed). Encyclopedia Analytical Chemistry (2000), John Wiley & sons Ltd., Chichester 302-320 (invited contribution)
2. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
3. Henderson B.W., and Dougherty T.J. How does photodynamic therapy work?. Photochem. Photobiol. 55 (1992) 145-157
4. Wu A.M., Chen W., Raubitschek A., Williams L.E., Neumaier M., Fischer R., Hu S.Z., Odom-Maryon T., Wong J.Y., and Shively J.E. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers. Immunotechnology 2 (1996) 21-36
5. Adams G.P., Schier R., McCall A.M., Crawford R.S., Wolf E.J., Weiner L.M., and Marks J.D. Prolonged in vivo tumor retention of a human diabody targeting the extracellular domain of human her2/neu. Brit. J. Cancer. 77 (1998) 1405-1412
6. Lister-James J., Moyer B.R., and Dean T. Small peptides radiolabeled with 99mTc. Quart. J. Nucl. Med. 40 (1996) 221-233
7. Maeda H. Polymer conjugated macromolecular drugs for tumor-specific targeting. In: Domb A.J. (Ed). Polymeric Site-specific Pharmacotherapy (1994), John Wiley & Sons, Inc., New York 96-116
8. Matsamura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanisms of tumoritropic accumulation of protein and the antitumor agent SMANCS. Cancer Res. 46 (1986) 6387-6392
9. Duncan R., and Sat Y.N. Tumor targeting by enhanced permeability and retention (EPR) effect. Ann. Oncol. 9 2 (1998) 39-52
10. Vasey P.A., Kaye S.B., Morrison R., Twelves C., Wilson P., Duncan R., Thomson A.H., Murray L.S., Hilditch T.E., Murray T., Burtles S., Fraier D., Frigerio E., and Cassidy J. Phase I clinical and pharmacokinetic study of PK1 (HPMA copolymer doxorubicin): first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Clin. Cancer Res. 5 (1999) 83-94
11. Peters Jr. T. Historical perspective. In: Peters Jr. T. (Ed). All About Albumin: Biochemistry, Genetics and Medical Application (1996), Academic Press, San Diego 1-8
12. Carter D.C., and Ho J.X. Structure of serum albumin. Adv. Protein Chem. 45 (1994) 153-203
13. He X.M., and Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 358 (1992) 209-215
14. Peters Jr. T. Serum albumin. Adv. Protein Chem. 37 (1985) 161-245
15. Langer K., Coester C., von Briesen H., and Kreuter J. Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid (PNA). Eur. J. Pharm. Biopharm. 49 (2000) 303-307
16. Weber C., Kreuter J., and Langer K. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups. Int. J. Pharm. 211 (2000) 67-78
17. Langer K., Balthasar S., Vogel V., Dinauer N., von Briesen H., and Schubert D. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int. J. Pharm. 257 (2003) 169-180
18. Röder B., Näther D., Lewald T., Braune M., Freyer W., and Nowak Ch. Photophysical properties and photodynamic activity in vivo of some tetrapyrroles. Biophys. Chem. 35 (1990) 303-312 (invited paper)
19. B. Röder, S. Nicklisch, G. Wischnewsky, E. Slawaticki, H. Meffert, Mittel zur Behandlung von Hauterkrankungen und Tumoren, Patent 08. October1984, WP 248 282.
20. Paul A., Hackbarth S., Mölich A., Luban C., Oelckers S., Böhm F., and Röder B. Comparative study on the photosensitization of jurkat cells in vitro by pheophorbide-a and a pheophorbide-a diaminobutane poly-propylene-imine dendrimer complex. Laser Phys. 13 (2003) 22-29
21. Rancan F., Helmreich M., Mölich A., Jux N., Hirsch A., Röder B., Witt C., and Böhm F. Fullerene-pyroPheophorbide a complexes as sensitizer for photodynamic therapy: uptake and photo-induced cytotoxicity on jurkat cells. J. Photochem. Photobiol. B 80 (2005) 1-7
22. Regehly M., Ermilov E.A., Helmreich M., Hirsch A., Jux N., and Röder B. Photoinduced energy and electron transfer processes in hexapyropheophorbide a-fullerene [C60] molecular systems. J. Phys. Chem. B 111 (2007) 998-1006
23. Makarov S., Litwinski C., Ermilov E.A., Suvorova O., Röder B., and Wöhrle D. Synthesis and photophysical properties of annulated dinuclear and trinuclear phthalocyanines. Chem. Eur. J. 12 (2006) 1468-1474
24. Bensasson R.V., Land E.J., and Truscott T.G. Excited States and Free Radicals in Biology and Medicine (1993), Oxford Univ. Press, Oxford
25. Oelckers S., Sczepan M., Hanke T., and Röder B. Time-resolved detection of singlet oxygen luminescence in red ghost cell suspensions. J. Photochem. Photobiol. B 39 (1997) 219-223
26. Hackbarth S., Ermilov E.A., and Röder B. Interaction of pheophorbide a molecules covalently linked to DAB dendrimers. Opt. Commun. 248 (2005) 295-306
27. Röder B., Hanke T., Oelckers S., Hackbarth S., and Symietz C. Photophysical properties of pheophorbide a in solution and in model membrane systems. J. Porphyrins Phthalocyanines 4 (2000) 37-44
28. Spiller W., Kliesch H., Wöhrle D., Hackbarth S., Röder B., and Schnurpfeil G. Singlet oxygen quantum yields of different photosensitizers in polar solvents and micellar solutions. J. Porphyrins Phthalocyanines 2 (1998) 145-158
29. Langer K., Anhorn M.G., Steinhauser I., Dreis S., Celebi D., Schrickel N., Faust S., and Vogel V. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. Int. J. Pharm. 347 (2008) 109-117
30. Hackbarth S., Honeffer V., Wiehe A., Hillenkamp F., and Röder B. Photophysical properties of pheophorbide-a-substituted diaminobutane poly-propylene-imine dendrimer. Chem. Phys. 269 (2001) 339-346
31. Lee W.Y., Lim D.S., Ko S.H., Park Y.J., Ryu K.S., Ahn M.Y., Kim Y.R., Lee D.W., and Cho C.W. Photoactivation of pheophorbide a induces a mitochondrial-mediated apoptosis in Jurkat leukaemia cells. J. Photochem. Photobiol. 75 (2004) 119-126